Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 896 of 5804
-
New drug cocktails aim to beat river blindness
Disease control OngoingThis study will investigate the safety and effectiveness of combination regimens in persons with onchocerciasis when it is administered after pre-treatment with ivermectin to clear or greatly reduce microfilariae from the skin and eyes.
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New knee implant could help avoid full replacement
Disease control Recruiting nowA multicenter, open-label, single-arm, pivotal study to evaluate the safety and effectiveness of the HYALEX Freestyle Resurfacing System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment, wi…
Phase: NA • Sponsor: Hyalex Orthopaedics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a party drug ease PTSD?
Symptom relief CompletedThis study is evaluating the safety and efficacy of methylone in adults with PTSD. The study is conducted in two parts. * Part A is open-label and will enroll up to 15 participants with PTSD * Part B is randomized (1:1:1), single-blind and will enroll up to 45 participants with …
Phase: PHASE2 • Sponsor: Transcend Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New ointment shows promise for restoring skin color in vitiligo
Disease control CompletedThis is a multicenter, randomized, double-blind, vehicle-controlled phase II study of MH004 Ointment with a 28-week open-label long-term safety extension period. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and primary efficacy of MH004 Oint…
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Diabetes drug may shield hepatitis b patients from liver failure
Disease control Recruiting nowThis is a five-year, double blinded, randomised trial of dapagliflozin versus placebo in patients with chronic hepatitis B and DM or IFG complicated with compensated advanced chronic liver disease (cACLD). 412 subjects will be recruited. Subject will be randomly assigned to recei…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New depression pill SP-624 enters Mid-Stage trial
Symptom relief OngoingThis is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.
Phase: PHASE2 • Sponsor: Sirtsei Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New 90-Minute test could save lives in sepsis emergencies
Diagnosis Recruiting nowSepsis is a disruption of homeostasis in the human body in response to bloodstream infection and is associated with a high risk of mortality. Worldwide, sepsis is affecting approximately 30 million people and resulting in six million deaths. Blood culture is a specific blood sa…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Robot vs. manual: which tool best spots lung cancer?
Diagnosis OngoingMulti-center randomized controlled study designed to compare the diagnostic yield of ION™ Endoluminal System with electromagnetic navigation bronchoscopy in patients undergoing transbronchial sampling procedure of peripheral pulmonary nodules.
Phase: NA • Sponsor: Intuitive Surgical • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Brain-Based biofeedback could rewire walking after stroke
Disease control TerminatedThe purpose of this study is to compare two interventions currently used to improve gait and lower limb function in individuals with chronic stroke (i.e., high-intensity gait training and high-intensity gait training with functional electrical stimulation (FES)) with novel interv…
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Prunes and calcium: a tasty shield against bone loss?
Prevention Recruiting nowThe objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.
Phase: NA • Sponsor: San Diego State University • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could fewer stents mean better recovery after a heart attack?
Disease control Recruiting nowThe objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI). Randomizat…
Phase: NA • Sponsor: Hospital Universitario La Fe • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a poop transplant ease autism symptoms?
Disease control Recruiting nowThis study aims to evaluate the efficacy of fecal microbiota transplantation on the gastrointestinal symptoms, autistic symptoms and emotional behavior symptoms of patients with autism spectrum disorder, and investigate the relations between the brain-gut axis, cytokines and auti…
Phase: PHASE1, PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
PTSD patients get extended relief: methylone study shows promise for Long-Term control
Disease control CompletedThis is an extension study of participants who previously completed a Transcend-sponsored clinical trial evaluating TSND-201 as a treatment for PTSD. Participants will be followed for up to 52 weeks. During the 52 week period, PTSD symptoms and safety will be assessed monthly. …
Phase: PHASE2 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can Play-Based therapy boost skills in autistic kids? major study launches
Disease control Recruiting nowThis study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase t…
Phase: NA • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can virtual checkups save new Moms' lives? major trial launches
Disease control Recruiting nowThe purpose of this study is to compare two complex, multi-component evidence-based postpartum interventions in underserved populations of lower socioeconomic status in an effort to reduce maternal morbidity and mortality.
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New video program aims to ease suicidal thoughts in hospitalized teens
Symptom relief OngoingThe goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: * Can the I-CARE program be used at the medical hospitals and do the patients and hospita…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New shot could help when blood pressure pills fall short
Disease control CompletedThe purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and hypertension not adequately controlled by standard of care antihypertensive medications.
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Short talk therapy may stop PTSD before it starts
Prevention Recruiting nowThe purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Can a simple blood test make albumin therapy smarter for liver patients?
Disease control Recruiting nowThe goal of this clinical biomarker validation trial is to test the effect of a predictive biomarker panel to human albumin infusions in patients with liver cirrhosis and ascites. The main questions it aims to answer are: * If the predictive biomarker panel can identify patients…
Phase: PHASE3 • Sponsor: Aleksander Krag • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Ketamine's secret in OCD: opioid system may hold key
Symptom relief Recruiting nowThe purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC